Literature DB >> 8190113

Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor.

R A Leppik1, R C Miller, M Eck, J L Paquet.   

Abstract

The purpose of this study was to explore the role of acidic amino acids in the allosteric behavior of gallamine at the m2 receptor. This was achieved by first mutating the acidic residues to neutral residues by site-directed mutagenesis. Both the parent and mutated receptors were expressed in mouse fibroblast A9L cells and characterized pharmacologically. The two main methods used were (i) Schild analysis of equilibrium binding data and (ii) study of the effect of gallamine on the dissociation kinetics of N-methylscopolamine. The Schild analysis gave an estimate of the affinity of gallamine for the allosteric site (KdA) and also a measure of the level of cooperativity (alpha) between the allosteric and primary binding sites. For the receptors studied, a good agreement was found between the alpha KdA values calculated from the Schild analysis and the IC50 values for the effect of gallamine on the N-methylscopolamine off-rate. One mutated receptor, in which the acidic EDGE (Glu-Asp-Gly-Glu) sequence of the putative third outer domain was changed to the neutral LAGQ (Leu-Ala-Gly-Gin) sequence, displayed an 8-fold reduction in affinity for gallamine at the allosteric site, in comparison with the parent receptor. The level of cooperatively between the allosteric and primary binding sites in this mutant was 46% of that of the parent receptor. A second mutated receptor, in which Asp-97 (near the top of putative transmembrane domain 3) was changed to asparagine, was found to have a level of cooperativity between sites 58% of that of the parent but was found not to be affected with respect to the affinity of gallamine for the allosteric site. When all of the acidic groups on the outer side were changed to neutral residues, there was still only an 8.6-fold reduction in gallamine affinity for the allosteric site, but the level of cooperativity was reduced to 19% of that found in the parent receptor. The results suggest that the allosteric site for gallamine binding in the m2 receptor residues at or near the putative third outer domain and that both the EDGE motif and Asp-97 play an essential role in the interaction between the two sites. However, none of the acidic amino acids mutated were found to be critical for binding at the allosteric site.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8190113

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  22 in total

1.  Mutagenesis of nucleophilic residues near the orthosteric binding pocket of M1 and M2 muscarinic receptors: effect on the binding of nitrogen mustard analogs of acetylcholine and McN-A-343.

Authors:  Hinako Suga; Gregory W Sawyer; Frederick J Ehlert
Journal:  Mol Pharmacol       Date:  2010-07-19       Impact factor: 4.436

Review 2.  G Protein-Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action.

Authors:  Stacy Gelhaus Wendell; Hao Fan; Cheng Zhang
Journal:  Pharmacol Rev       Date:  2020-01       Impact factor: 25.468

3.  Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist.

Authors:  Maren Grossmüller; Johannes Antony; Christian Tränkle; Ulrike Holzgrabe; Klaus Mohr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-12-16       Impact factor: 3.000

4.  Identification of orthosteric and allosteric site mutations in M2 muscarinic acetylcholine receptors that contribute to ligand-selective signaling bias.

Authors:  Karen J Gregory; Nathan E Hall; Andrew B Tobin; Patrick M Sexton; Arthur Christopoulos
Journal:  J Biol Chem       Date:  2010-01-05       Impact factor: 5.157

Review 5.  Rational design of dualsteric GPCR ligands: quests and promise.

Authors:  Klaus Mohr; Christian Tränkle; Evi Kostenis; Elisabetta Barocelli; Marco De Amici; Ulrike Holzgrabe
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

6.  Activation of muscarinic acetylcholine receptors via their allosteric binding sites.

Authors:  J Jakubík; L Bacáková; V Lisá; E E el-Fakahany; S Tucek
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

Review 7.  Autoantibodies as Endogenous Modulators of GPCR Signaling.

Authors:  Meredith A Skiba; Andrew C Kruse
Journal:  Trends Pharmacol Sci       Date:  2020-12-24       Impact factor: 14.819

8.  Molecular mechanisms of bitopic ligand engagement with the M1 muscarinic acetylcholine receptor.

Authors:  Peter Keov; Laura López; Shane M Devine; Celine Valant; J Robert Lane; Peter J Scammells; Patrick M Sexton; Arthur Christopoulos
Journal:  J Biol Chem       Date:  2014-07-08       Impact factor: 5.157

9.  Molecular mechanisms of action and in vivo validation of an M4 muscarinic acetylcholine receptor allosteric modulator with potential antipsychotic properties.

Authors:  Katie Leach; Richard E Loiacono; Christian C Felder; David L McKinzie; Adrian Mogg; David B Shaw; Patrick M Sexton; Arthur Christopoulos
Journal:  Neuropsychopharmacology       Date:  2009-11-25       Impact factor: 7.853

10.  Divergence of allosteric effects of rapacuronium on binding and function of muscarinic receptors.

Authors:  Jan Jakubík; Alena Randáková; Esam E El-Fakahany; Vladimír Dolezal
Journal:  BMC Pharmacol       Date:  2009-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.